| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042141384 |
| P356 | DOI | 10.1007/S13277-016-5274-9 |
| P698 | PubMed publication ID | 27492457 |
| P50 | author | Aleksi Šedo | Q10768979 |
| Petr Bušek | Q51030360 | ||
| Zuzana Zemanová | Q52150793 | ||
| P2093 | author name string | Eva Balaziova | |
| Evzen Krepela | |||
| Robert Tomas | |||
| Martin Syrucek | |||
| Jaromir Belacek | |||
| Marek Hilser | |||
| Ivana Matrasova | |||
| P2860 | cites work | Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 |
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer | Q28181638 | ||
| Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Q29619677 | ||
| FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells | Q31018027 | ||
| Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies. | Q31095363 | ||
| Molecular characterization of human breast tumor vascular cells | Q33327647 | ||
| Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity | Q33555573 | ||
| Tumoral immune suppression by macrophages expressing fibroblast activation protein-α and heme oxygenase-1. | Q33557006 | ||
| Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells | Q33570788 | ||
| Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma | Q33654184 | ||
| Short hairpin RNA targeting of fibroblast activation protein inhibits tumor growth and improves the tumor microenvironment in a mouse model | Q34049485 | ||
| Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer. | Q34816275 | ||
| Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis | Q35182174 | ||
| Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma | Q35678312 | ||
| Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion | Q35749727 | ||
| Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations | Q35754294 | ||
| Genetic pathways to primary and secondary glioblastoma | Q35757144 | ||
| Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells. | Q35862799 | ||
| A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice | Q36470281 | ||
| Fibrocytes: emerging effector cells in chronic inflammation | Q36690680 | ||
| Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors--good or evil? | Q36992442 | ||
| Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice | Q37452281 | ||
| The brain tumor microenvironment. | Q37858940 | ||
| Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies. | Q38011389 | ||
| Fibroblast activation protein in remodeling tissues | Q38029752 | ||
| Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features. | Q38074100 | ||
| Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. | Q38182507 | ||
| Brain mesenchymal stem cells: The other stem cells of the brain? | Q38207598 | ||
| Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity | Q38498538 | ||
| Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy. | Q38797421 | ||
| Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro | Q38906398 | ||
| Fibroblast activation protein-α promotes ovarian cancer cell proliferation and invasion via extracellular and intracellular signaling mechanisms | Q39137886 | ||
| Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions. | Q39538239 | ||
| SOX2 expression and amplification in gliomas and glioma cell lines | Q39553321 | ||
| Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha | Q39635625 | ||
| Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumors | Q39667924 | ||
| TWIST1 promotes invasion through mesenchymal change in human glioblastoma | Q39677871 | ||
| Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens | Q39842716 | ||
| Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer. | Q40151296 | ||
| Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer | Q40566263 | ||
| Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin | Q43090748 | ||
| Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow | Q46569125 | ||
| Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts | Q46831061 | ||
| Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines | Q48154511 | ||
| Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. | Q48405360 | ||
| Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis | Q50324744 | ||
| Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties. | Q55461236 | ||
| Matrix metalloproteinase 2 attenuates brain tumour growth, while promoting macrophage recruitment and vascular repair. | Q55463274 | ||
| Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade. | Q55467813 | ||
| Collagens, integrins and the mesenchymal drift in glioblastomas: A comparison of biopsy specimens, spheroid and early monolayer cultures | Q55481758 | ||
| Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets | Q59446928 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13961-13971 | |
| P577 | publication date | 2016-08-04 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma | |
| P478 | volume | 37 |
| Q100751371 | Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy |
| Q47285215 | Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts |
| Q89831540 | Fibroblast Activation Protein Regulates Lesion Burden and the Fibroinflammatory Response in Apoe-Deficient Mice in a Sexually Dimorphic Manner |
| Q90323312 | Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment |
| Q30241921 | Intercellular crosstalk in human malignant melanoma |
| Q47660087 | Low expression of miR-30a-5p induced the proliferation and invasion of oral cancer via promoting the expression of FAP. |
| Q41592822 | MM-BMSCs induce naïve CD4+ T lymphocytes dysfunction through fibroblast activation protein α |
| Q59446927 | Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics |
Search more.